Progesterone | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Progesterone
Health Canada Patents

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Symbiotec Progesterone

Contact Supplier

pharmacompass-1-m-2025-08-25

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Progesterone

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

113 API Suppliers, 29 USDMF, 18 CEP/COS, 4 JDMF, 5 EU WC, 5 KDMF, 62 NDC API, 22 Listed Suppliers, $ API Reference Price

113 API Suppliers
29 USDMF
18 CEP/COS
4 JDMF
5 EU WC
5 KDMF
62 NDC API
22 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

64 Drugs in Development

64 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

171 FDF Dossiers, 38 FDA Orange Book, 56 Europe, 18 Canada, 9 Australia, 5 South Africa, 45 Listed Dossiers

171 FDF Dossiers
38 FDA Orange Book
56 Europe
18 Canada
9 Australia
5 South Africa
45 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 100MG, CAPSULE;ORAL - 200MG, GEL;VAGINAL - 4%, GEL;VAGINAL - 8%, CAPSULE;ORAL - 0.5MG;100MG, CAPSULE;ORAL - 1MG;100MG

CAPSULE;ORAL - 100MG
CAPSULE;ORAL - 200MG
GEL;VAGINAL - 4%
GEL;VAGINAL - 8%
CAPSULE;ORAL - 0.5MG;100MG
CAPSULE;ORAL - 1MG;100MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 4 SPI Pharma, 8 DKSH, 3 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 2 Kirsch Pharma, 4 ACG Worldwide, 3 Actylis, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 1 CD Formulation, 1 Clariant, 1 Corel Pharma Chem, 3 DFE Pharma, 2 Finar, 2 Gangwal Chemicals, 3 Ingredion Pharma Solutions, 9 Kerry, 1 Keval Exports, 3 Lonza Capsugel, 3 Lubrizol Life Science Health, 7 Microlex e.U, 1 Nitika Pharmaceutical Specialities, 7 Pluviaendo, 2 Prachin Chemical, 1 Qualicaps, 9 Roquette, 2 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Sigachi Industries, 2 Silverline Chemicals, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

32 Fillers, Diluents & Binders, 13 Granulation, 13 Topical, 12 Direct Compression, 12 Lubricants & Glidants, 12 Parenteral, 12 Disintegrants & Superdisintegrants, 11 Thickeners and Stabilizers, 9 Coating Systems & Additives, 8 Empty Capsules, 7 Taste Masking, 6 Film Formers & Plasticizers, 5 Emulsifying Agents, 5 Co-Processed Excipients, 4 Solubilizers, 3 API Stability Enhancers, 3 Coloring Agents, 3 Rheology Modifiers, 3 Controlled & Modified Release, 3 Chewable & Orodispersible Aids, 2 Surfactant & Foaming Agents

32 Fillers, Diluents & Binders
13 Granulation
13 Topical
12 Direct Compression
12 Lubricants & Glidants
12 Parenteral
12 Disintegrants & Superdisintegrants
11 Thickeners and Stabilizers
9 Coating Systems & Additives
8 Empty Capsules
7 Taste Masking
6 Film Formers & Plasticizers
5 Emulsifying Agents
5 Co-Processed Excipients
4 Solubilizers
3 API Stability Enhancers
3 Coloring Agents
3 Rheology Modifiers
3 Controlled & Modified Release
3 Chewable & Orodispersible Aids
2 Surfactant & Foaming Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 47 News #PharmaBuzz

1 Data Compilation #PharmaFlow
47 News #PharmaBuzz

GLOBAL SALES INFORMATION

15 US Medicaid Prescriptions, 46 Regulatory FDF Prices

15 US Medicaid Prescriptions
46 Regulatory FDF Prices

MARKET PLACE

27 APIs, 18 FDF Dossiers

27 APIs
18 FDF Dossiers

PATENTS & EXCLUSIVITIES

42 US Patents, 5 Health Canada Patents

42 US Patents
5 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 3 JP, 4 Others

3 EDQM
3 JP
4 Others

$ API Ref.Price (USD/KG) : 224 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

5 All

01 1Bereskin & Parr LLP

02 2Ferring Inc.

03 2Knight Therapeutics Inc

filter Patent Reset all filters

5 All

01 12519418

02 22568823

03 22856520

filter Product Reset all filters

5 All

01 2ESTRADIOL HEMIHYDRATE | PROGESTERONE

02 3PROGESTERONE

filter Dosage Reset all filters

5 All

01 2CAPSULE

02 1SOLUTION

03 2TABLET (EFFERVESCENT)

filter Exp Date Reset all filters

5 All

01 12025-09-14

02 22026-11-24

03 22032-11-21

Product Main Page

01

Ferring Inc.

Progesterone

CPhI Korea

Not Confirmed

Ferring Inc.

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-11-24

Date Granted : 2012-02-07

Progesterone

Brand Name : ENDOMETRIN

Patent Number : 2568823

Filing Date : 2006-11-24

Strength per Unit : 100 mg

Dosage Form : TABLET (EFFERVESCENT)

Human Or VET : Human

Route of Administration : VAGINAL

Patent Expiration Date : 2026-11-24

Date Granted : 2012-02-07

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Ferring Inc.

Progesterone

CPhI Korea

Not Confirmed

Ferring Inc.

Country

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-11-24

Date Granted : 2012-02-07

Progesterone

Brand Name : ENDOMETRIN

Patent Number : 2568823

Filing Date : 2006-11-24

Strength per Unit : 100 mg

Dosage Form : TABLET (EFFERVESCENT)

Human Or VET : Human

Route of Administration : VAGINAL

Patent Expiration Date : 2026-11-24

Date Granted : 2012-02-07

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Knight Therapeutics Inc

Estradiol, Progesterone

CPhI Korea

Not Confirmed

Knight Therapeutics Inc

Country

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-11-21

Date Granted : 2021-04-06

Estradiol, Progesterone

Brand Name : BIJUVA

Patent Number : 2856520

Filing Date : 2012-11-21

Strength per Unit : 0.5mg / 100mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2032-11-21

Date Granted : 2021-04-06

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Knight Therapeutics Inc

Estradiol, Progesterone

CPhI Korea

Not Confirmed

Knight Therapeutics Inc

Country

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-11-21

Date Granted : 2021-04-06

Estradiol, Progesterone

Brand Name : BIJUVA

Patent Number : 2856520

Filing Date : 2012-11-21

Strength per Unit : 1.0mg / 100mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2032-11-21

Date Granted : 2021-04-06

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Bereskin & Parr LLP

Progesterone

CPhI Korea

Not Confirmed

Bereskin & Parr LLP

Country

CPhI Korea

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-09-14

Date Granted : 2013-06-11

Progesterone

Brand Name : INPROSUB

Patent Number : 2519418

Filing Date : 2005-09-14

Strength per Unit : 25mg / 1.112mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2025-09-14

Date Granted : 2013-06-11

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!